Use of Medication Therapy for Opioid Use Disorder Increased 2010 to 2019
However, 86.6 percent of people with opioid use disorder are not receiving medication treatment
Narcotic Analgesics
Combating Inappropriate Polypharmacy
Older adults are especially prone to inappropriate polypharmacy because they commonly have multiple medical problems and see a variety of specialists.
Preset Opioid Rx May Not Impact Pain Control After Tonsillectomy
Default number of doses in opioid prescriptions lowered for teens and young adults undergoing tonsillectomy
Mislabeling Common With OTC Topical Cannabis Products
On average, products contained 10 to 20 percent more cannabidiol than advertised overall
Opioid Rx Dosage Higher for Adults With Cerebral Palsy, Spina Bifida
Higher prescription of oral morphine equivalents seen for adults with cerebral palsy, spina bifida across pain categories
MPR Weekly Dose Podcast #123
Pharmacists now allowed to prescribe Paxlovid; new dosing recommendations for Evusheld; abuse-deterrent opioid analgesic; Priority Review for early Alzheimer disease treatment; morphine tablets recalled.
RoxyBond, an Abuse-Deterrent Opioid Analgesic, Now Available
RoxyBond is an abuse-deterrent formulation of immediate-release oxycodone that features a unique abuse-deterrent technology.
Morphine Sulfate Extended-Release Tablets Recalled Due to Incorrect Labeling
Patients prescribed the 30mg dose who receive the 60mg dose may potentially be at risk for overdose and death.
Opioid Tapering Tied to Overdose, Withdrawal, Mental Health Risks for Up to Two Years
Authors hope findings will ‘inform a more cautious approach to decisions around opioid dose tapering’
All-Cause ED Visits, Hospitalization Up With Cannabis Use
No significantly increased risk of respiratory-related emergency department use or hospitalization for cannabis users versus controls
